{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:38:06Z","timestamp":1793299086157,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023MB082"],"award-info":[{"award-number":["ZR2023MB082"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-58312-5","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T14:33:39Z","timestamp":1744122819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Inhalable liposomal delivery of osimertinib and DNA for treating primary and metastasis lung cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Xianglei","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yankun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5521-1628","authenticated-orcid":false,"given":"Xiaogang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengchang","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7081-7356","authenticated-orcid":false,"given":"Guimei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"58312_CR1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.2032","volume":"39","author":"P Rahman","year":"2021","unstructured":"Rahman, P. et al. Clinical and genomic predictors of brain metastases (BM) in non-small cell lung cancer (NSCLC): an AACR Project GENIE analysis. J. Clin. Oncol. 39, 2032 (2021).","journal-title":"J. Clin. Oncol."},{"key":"58312_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004863","volume":"10","author":"S Peters","year":"2022","unstructured":"Peters, S., Paz-Ares, L., Herbst, R. S. & Reck, M. Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospects. J. Immunother. Cancer 10, e004863 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"58312_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202201516","volume":"34","author":"J Huang","year":"2022","unstructured":"Huang, J. et al. Targeted drug\/gene\/photodynamic therapy via a stimuli-responsive dendritic-polymer-based nanococktail for treatment of EGFR-TKI-resistant non-small-cell lung cancer. Adv. Mater. 34, e2201516 (2022).","journal-title":"Adv. Mater."},{"key":"58312_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s43018-021-00195-8","volume":"2","author":"A Passaro","year":"2021","unstructured":"Passaro, A., J\u00e4nne, P. A., Mok, T. & Peters, S. Overcoming therapy resistance in EGFR-mutant lung cancer. Nat. Cancer 2, 377\u2013391 (2021).","journal-title":"Nat. Cancer"},{"key":"58312_CR5","first-page":"377","volume":"2","author":"JP Robichaux","year":"2021","unstructured":"Robichaux, J. P. et al. Structure-based classification predicts drug response in EGFR-mutant NSCLC. Nature 2, 377\u2013391 (2021).","journal-title":"Nature"},{"key":"58312_CR6","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41586-023-05729-x","volume":"616","author":"M Al Bakir","year":"2023","unstructured":"Al Bakir, M. et al. The evolution of non-small cell lung cancer metastases in TRACERx. Nature 616, 534\u2013542 (2023).","journal-title":"Nature"},{"key":"58312_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01356-0","volume":"20","author":"MB Uddin","year":"2021","unstructured":"Uddin, M. B., Wang, Z. & Yang, C. The m6A RNA methylation regulates oncogenic signaling pathways driving cell malignant transformation and carcinogenesis. Mol. Cancer 20, 61 (2021).","journal-title":"Mol. Cancer"},{"key":"58312_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.omtn.2019.11.022","volume":"19","author":"W Zhao","year":"2020","unstructured":"Zhao, W. et al. Epigenetic regulation of m6A modifications in human cancer. Mol. Ther. Nucleic Acids 19, 405\u2013412 (2020).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"58312_CR9","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s41556-020-00580-y","volume":"22","author":"H Huang","year":"2020","unstructured":"Huang, H. et al. Recognition of RNA N 6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat. Cell Biol. 22, 1288 (2020).","journal-title":"Nat. Cell Biol."},{"key":"58312_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01447-y","volume":"21","author":"W Wan","year":"2022","unstructured":"Wan, W. et al. METTL3\/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer. Mol. Cancer 21, 60 (2022).","journal-title":"Mol. Cancer"},{"key":"58312_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202206744","volume":"10","author":"X Yang","year":"2023","unstructured":"Yang, X. et al. m6A-dependent modulation via IGF2BP3\/MCM5\/Notch axis promotes partial EMT and LUAD metastasis. Adv. Sci. 10, e2206744 (2023).","journal-title":"Adv. Sci."},{"key":"58312_CR12","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41565-023-01548-3","volume":"19","author":"AY Jiang","year":"2023","unstructured":"Jiang, A. Y. et al. Combinatorial development of nebulized mRNA delivery formulations for the lungs. Nat. Nanotechnol. 19, 364\u2013375 (2023).","journal-title":"Nat. Nanotechnol."},{"key":"58312_CR13","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1158\/0008-5472.CAN-22-3059","volume":"83","author":"Z Lin","year":"2023","unstructured":"Lin, Z. et al. Metabolic reprogramming driven by IGF2BP3 promotes acquired resistance to EGFR inhibitors in non\u2013small cell lung cancer. Cancer Res 83, 2187\u20132207 (2023).","journal-title":"Cancer Res"},{"key":"58312_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202210579","volume":"35","author":"AI Salazar-Puerta","year":"2023","unstructured":"Salazar-Puerta, A. I. et al. Engineered extracellular vesicles derived from dermal fibroblasts attenuate inflammation in a murine model of acute lung injury. Adv. Mater. 35, e2210579 (2023).","journal-title":"Adv. Mater."},{"key":"58312_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202204910","volume":"35","author":"Q You","year":"2023","unstructured":"You, Q. et al. m6A reader YTHDF1-targeting engineered small extracellular vesicles for gastric cancer therapy via epigenetic and immune regulation. Adv. Mater. 35, e2204910 (2023).","journal-title":"Adv. Mater."},{"key":"58312_CR16","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41565-023-01580-3","volume":"19","author":"M Liu","year":"2024","unstructured":"Liu, M., Hu, S., Yan, N., Popowski, K. D. & Cheng, K. Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity. Nat. Nanotechnol. 19, 565\u2013575 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"58312_CR17","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science 367, eaau6977 (2020).","journal-title":"Science"},{"key":"58312_CR18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41422-021-00491-z","volume":"31","author":"Z Fu","year":"2021","unstructured":"Fu, Z. et al. In vivo self-assembled small RNAs as a new generation of RNAi therapeutics. Cell Res. 31, 631\u2013648 (2021).","journal-title":"Cell Res."},{"key":"58312_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg3277","volume":"9","author":"QF Meng","year":"2023","unstructured":"Meng, Q. F. et al. Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates. Sci. Adv. 9, eadg3277 (2023).","journal-title":"Sci. Adv."},{"key":"58312_CR20","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41563-022-01404-0","volume":"22","author":"L Rotolo","year":"2023","unstructured":"Rotolo, L. et al. Species-agnostic polymeric formulations for inhalable messenger RNA delivery to the lung. Nat. Mater. 22, 369\u2013379 (2023).","journal-title":"Nat. Mater."},{"key":"58312_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202304419","volume":"62","author":"S Chi","year":"2023","unstructured":"Chi, S. et al. Biomimetic nanocomposites camouflaged with hybrid cell membranes for accurate therapy of early-stage glioma. Angew. Chem. Int. Ed. 62, e202304419 (2023).","journal-title":"Angew. Chem. Int. Ed."},{"key":"58312_CR22","doi-asserted-by":"publisher","first-page":"8370","DOI":"10.1021\/acsnano.2c02634","volume":"16","author":"W Wang","year":"2022","unstructured":"Wang, W. et al. Inhalable biomimetic protein corona-mediated nanoreactor for self-amplified lung adenocarcinoma ferroptosis therapy. ACS Nano 16, 8370\u20138387 (2022).","journal-title":"ACS Nano"},{"key":"58312_CR23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jconrel.2021.11.023","volume":"342","author":"L Herman","year":"2022","unstructured":"Herman, L., De Smedt, S. C. & Raemdonck, K. Pulmonary surfactant as a versatile biomaterial to fight COVID-19. J. Control. Release 342, 170\u2013188 (2022).","journal-title":"J. Control. Release"},{"key":"58312_CR24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jconrel.2018.10.012","volume":"291","author":"R Guagliardo","year":"2018","unstructured":"Guagliardo, R., P\u00e9rez-Gil, J., De Smedt, S. & Raemdonck, K. Pulmonary surfactant and drug delivery: focusing on the role of surfactant proteins. J. Control. Release 291, 116\u2013126 (2018).","journal-title":"J. Control. Release"},{"key":"58312_CR25","doi-asserted-by":"publisher","first-page":"eabj0624","DOI":"10.1126\/sciadv.abj0624","volume":"7","author":"X Yan","year":"2021","unstructured":"Yan, X., Pan, Q., Xin, H., Chen, Y. & Ping, Y. Genome-editing prodrug: targeted delivery and conditional stabilization of CRISPR-Cas9 for precision therapy of inflammatory disease. Sci. Adv. 7, eabj0624 (2021).","journal-title":"Sci. Adv."},{"key":"58312_CR26","doi-asserted-by":"publisher","first-page":"13611","DOI":"10.1021\/acsnano.3c02272","volume":"17","author":"S Yuan","year":"2023","unstructured":"Yuan, S. et al. Transforming cancer-associated fibroblast barrier into drug depots to boost chemo-immunotherapy in \u201cshooting fish in a barrel\u201d pattern. ACS Nano 17, 13611\u201313626 (2023).","journal-title":"ACS Nano"},{"key":"58312_CR27","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jconrel.2022.07.008","volume":"349","author":"IV Balyasnikova","year":"2022","unstructured":"Balyasnikova, I. V. et al. Indocarbocyanine nanoparticles extravasate and distribute better than liposomes in brain tumors. J. Control. Release 349, 413\u2013424 (2022).","journal-title":"J. Control. Release"},{"key":"58312_CR28","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41586-021-04234-3","volume":"601","author":"R Garcia-Martin","year":"2022","unstructured":"Garcia-Martin, R. et al. MicroRNA sequence codes for small extracellular vesicle release and cellular retention. Nature 601, 446\u2013451 (2022).","journal-title":"Nature"},{"key":"58312_CR29","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/s41551-021-00786-x","volume":"5","author":"MP Lokugamage","year":"2021","unstructured":"Lokugamage, M. P. et al. Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs. Nat. Biomed. Eng. 5, 1059\u20131068 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"58312_CR30","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1021\/acs.nanolett.9b03817","volume":"20","author":"D Nie","year":"2020","unstructured":"Nie, D. et al. Cancer-cell-membrane-coated nanoparticles with a yolk-shell structure augment cancer chemotherapy. Nano Lett. 20, 936\u2013946 (2020).","journal-title":"Nano Lett."},{"key":"58312_CR31","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-020-00342-0","volume":"5","author":"X Fu","year":"2020","unstructured":"Fu, X. et al. Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting. Signal Transduct. Target. Ther. 5, 262 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"58312_CR32","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.actbio.2022.12.010","volume":"157","author":"H Wu","year":"2023","unstructured":"Wu, H. et al. Multifunctional biomimetic nanoplatform based on photodynamic therapy and DNA repair intervention for the synergistic treatment of breast cancer. Acta Biomater. 157, 551\u2013565 (2023).","journal-title":"Acta Biomater."},{"key":"58312_CR33","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nnano.2017.57","volume":"12","author":"TT Smith","year":"2017","unstructured":"Smith, T. T. et al. In situ programming of leukaemia-specific t cells using synthetic DNA nanocarriers. Nat. Nanotechnol. 12, 813\u2013820 (2017).","journal-title":"Nat. Nanotechnol."},{"key":"58312_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01547-3","volume":"21","author":"Z Pan","year":"2022","unstructured":"Pan, Z. et al. Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR\/Src\/Erk\/SP1 signaling-mediated ERR\u03b1 re-expression. Mol. Cancer 21, 77 (2022).","journal-title":"Mol. Cancer"},{"key":"58312_CR35","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41551-021-00792-z","volume":"5","author":"D Gupta","year":"2021","unstructured":"Gupta, D. et al. Amelioration of systemic inflammation via the display of two different decoy protein receptors on extracellular vesicles. Nat. Biomed. Eng. 5, 1084\u20131098 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"58312_CR36","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj8207","volume":"8","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy. Sci. Adv. 8, eabj8207 (2022).","journal-title":"Sci. Adv."},{"key":"58312_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd6889","volume":"7","author":"W Li","year":"2021","unstructured":"Li, W. et al. BBB pathophysiology\u2013independent delivery of siRNA in traumatic brain injury. Sci. Adv. 7, eabd6889 (2021).","journal-title":"Sci. Adv."},{"key":"58312_CR38","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jconrel.2023.01.023","volume":"354","author":"R Wang","year":"2023","unstructured":"Wang, R. et al. Bio-fabricated nanodrugs with chemo-immunotherapy to inhibit glioma proliferation and recurrence. J. Control. Release 354, 572\u2013587 (2023).","journal-title":"J. Control. Release"},{"key":"58312_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s40824-019-0166-x","volume":"23","author":"D Chenthamara","year":"2019","unstructured":"Chenthamara, D. et al. Therapeutic efficacy of nanoparticles and routes of administration. Biomater. Res. 23, 20 (2019).","journal-title":"Biomater. Res."},{"key":"58312_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1224516","volume":"14","author":"IA Elcheva","year":"2023","unstructured":"Elcheva, I. A. et al. IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment. Front Immunol. 14, 1224516 (2023).","journal-title":"Front Immunol."},{"key":"58312_CR41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41565-022-01266-2","volume":"18","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy. Nat. Nanotechnol. 18, 193\u2013204 (2023).","journal-title":"Nat. Nanotechnol."},{"key":"58312_CR42","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41392-022-00872-9","volume":"7","author":"Y Jin","year":"2022","unstructured":"Jin, Y. et al. Targeting polarized phenotype of microglia via IL6\/JAK2\/STAT3 signaling to reduce NSCLC brain metastasis. Signal Transduct. Target Ther. 7, 52 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"58312_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01485-6","volume":"21","author":"Z Pan","year":"2022","unstructured":"Pan, Z. et al. EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3. Mol. Cancer 21, 16 (2022).","journal-title":"Mol. Cancer"},{"key":"58312_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2022.04.041","volume":"347","author":"X Fu","year":"2022","unstructured":"Fu, X. et al. Combination of oxaliplatin and POM\u22121 by nanoliposomes to reprogram the tumor immune microenvironment. J. Control. Release 347, 1\u201313 (2022).","journal-title":"J. Control. Release"},{"key":"58312_CR45","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","volume":"19","author":"DJ Propper","year":"2022","unstructured":"Propper, D. J. & Balkwill, F. R. Harnessing cytokines and chemokines for cancer therapy. Nat. Rev. Clin. Oncol. 19, 237\u2013253 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"58312_CR46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","volume":"21","author":"M Certo","year":"2021","unstructured":"Certo, M., Tsai, C. H., Pucino, V., Ho, P. C. & Mauro, C. Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat. Rev. Immunol. 21, 151\u2013161 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"58312_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113714","volume":"43","author":"Q Zhang","year":"2024","unstructured":"Zhang, Q. et al. EZH2\/G9a interact to mediate drug resistance in non-small-cell lung cancer by regulating the SMAD4\/ERK\/c-Myc signaling axis. Cell Rep. 43, 113714 (2024).","journal-title":"Cell Rep."},{"key":"58312_CR48","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.cell.2017.10.022","volume":"171","author":"MJ Topper","year":"2017","unstructured":"Topper, M. J. et al. Epigenetic therapy ties MYC depletion to reversing immune evasion and treating lung cancer. Cell 171, 1284\u20131300 (2017).","journal-title":"Cell"},{"key":"58312_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01841-8","volume":"2","author":"SW Yue","year":"2023","unstructured":"Yue, S. W. et al. m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism. Mol. Cancer 2, 137 (2023).","journal-title":"Mol. Cancer"},{"key":"58312_CR50","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.actbio.2022.12.054","volume":"158","author":"L Sun","year":"2023","unstructured":"Sun, L. et al. Gold nanoparticles inhibit tumor growth via targeting the Warburg effect in a c-Myc-dependent way. Acta Biomater. 158, 583\u2013598 (2023).","journal-title":"Acta Biomater."},{"key":"58312_CR51","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.cmet.2023.06.013","volume":"35","author":"H Rho","year":"2023","unstructured":"Rho, H., Terry, A. R., Chronis, C. & Hay, N. Hexokinase 2-mediated gene expression via histone lactylation is required for hepatic stellate cell activation and liver fibrosis. Cell Metab. 35, 1406\u20131423 (2023).","journal-title":"Cell Metab."},{"key":"58312_CR52","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1158\/2326-6066.CIR-16-0365","volume":"5","author":"HY Li","year":"2017","unstructured":"Li, H. Y. et al. The tumor microenvironment regulates sensitivity of murine lung tumors to PD-1\/PD-L1 antibody blockade. Cancer Immunol. Res5, 767\u2013777 (2017).","journal-title":"Cancer Immunol. Res"},{"key":"58312_CR53","first-page":"100925","volume":"19","author":"X Fu","year":"2024","unstructured":"Fu, X. et al. Immunotherapeutic hydrogel for co-delivery of STAT3 siRNA liposomes and lidocaine hydrochloride for postoperative comprehensive management of NSCLC in a single application. Asian J. Pharm. Sci. 19, 100925 (2024).","journal-title":"Asian J. Pharm. Sci."},{"key":"58312_CR54","doi-asserted-by":"publisher","first-page":"1909745","DOI":"10.1002\/adfm.201909745","volume":"30","author":"B Li","year":"2020","unstructured":"Li, B., Hao, G., Sun, B., Gu, Z. & Xu, Z. P. Engineering a therapy-induced \u201cimmunogenic cancer cell death\u201d amplifier to boost systemic tumor elimination. Adv. Funct. Mater. 30, 1909745 (2020).","journal-title":"Adv. Funct. Mater."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58312-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58312-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58312-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T13:19:26Z","timestamp":1744204766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58312-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["58312"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-58312-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"2 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3336"}}